Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers.

MLA

Martinez Chanza, Nieves, et al. “Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-Invasive Urinary Tract Cancers.” European Urology Oncology, vol. 3, no. 5, Oct. 2020, pp. 671–79. EBSCOhost, https://doi.org/10.1016/j.euo.2018.12.013.

APA

Martinez Chanza, N., Werner, L., Plimack, E., Yu, E. Y., Alva, A. S., Crabb, S. J., Powles, T., Rosenberg, J. E., Baniel, J., Vaishampayan, U. N., Berthold, D. R., Ladoire, S., Hussain, S. A., Milowsky, M. I., Agarwal, N., Necchi, A., Pal, S. K., Sternberg, C. N., Bellmunt, J., … Harshman, L. C. (2020). Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers. European Urology Oncology, 3(5), 671–679. https://doi.org/10.1016/j.euo.2018.12.013

Chicago

Martinez Chanza, Nieves, Lillian Werner, Elizabeth Plimack, Evan Y Yu, Ajjai S Alva, Simon J Crabb, Thomas Powles, et al. 2020. “Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-Invasive Urinary Tract Cancers.” European Urology Oncology 3 (5): 671–79. doi:10.1016/j.euo.2018.12.013.